Literature DB >> 2703540

Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

J E Martin1, B J Jenkins, R J Zuk, J P Blandy, S I Baithun.   

Abstract

One hundred cases of transitional cell carcinoma of the bladder were studied to determine whether squamous metaplasia and other histological features within the bladder can be of value in predicting outcome of treatment with radiotherapy. Sixty cases showed the changes of squamous metaplasia, and of this group 46 (78%) failed to respond to radiotherapy. A significant response rate of 90% was seen in the 40 tumours without squamous metaplasia. It is concluded that transitional cell carcinomas of the bladder showing squamous metaplasia are mainly resistant to radiotherapy and alternative treatment methods should be sought.

Entities:  

Mesh:

Year:  1989        PMID: 2703540      PMCID: PMC1141863          DOI: 10.1136/jcp.42.3.250

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  A study of 52 cases of adenocarcinoma of the bladder.

Authors:  D G Thomas; A M Ward; J L Williams
Journal:  Br J Urol       Date:  1971-02

2.  Pathology an prognosis folowing total cystectomy for carcinoma of bladder.

Authors:  A Pomerance
Journal:  Br J Urol       Date:  1972-08

3.  Proceedings: The pathology of cancer of the bladder.

Authors:  R C Pugh
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

Review 4.  Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy.

Authors:  H J Bloom; W F Hendry; D M Wallace; R G Skeet
Journal:  Br J Urol       Date:  1982-04

5.  The heterogeneity of invasive bladder carcinoma and different responses to treatment.

Authors:  N H Slack; G R Prout
Journal:  J Urol       Date:  1980-05       Impact factor: 7.450

6.  Bladder cancer as seen in giant histologic sections.

Authors:  E A Soto; G H Friedell; A J Tiltman
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

7.  T3 bladder cancer--the case for salvage cystectomy.

Authors:  J P Blandy; H R England; S J Evans; H F Hope-Stone; G M Mair; B S Mantell; R T Oliver; A M Paris; R A Risdon
Journal:  Br J Urol       Date:  1980-12

8.  Squamous carcinoma of urinary bladder.

Authors:  S I Tannenbaum; C C Carson; A Tatum; D F Paulson
Journal:  Urology       Date:  1983-12       Impact factor: 2.649

9.  Invasive bladder cancer: tumor configuration, lymphatic invasion and survival.

Authors:  N M Heney; K Proppe; G R Prout; P P Griffin; W U Shipley
Journal:  J Urol       Date:  1983-11       Impact factor: 7.450

10.  Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy.

Authors:  M A Boileau; D E Johnson; R C Chan; M O Gonzales
Journal:  Urology       Date:  1980-12       Impact factor: 2.649

View more
  17 in total

1.  Divergent squamous differentiation in upper urothelial carcinoma-comparative clinicopathological and molecular study.

Authors:  Ljubinka Jankovic Velickovic; Zana Dolicanin; Takanori Hattori; Ivana Pesic; Biljana Djordjevic; Mariola Stojanovic; Jablan Stankovic; Milan Visnic; Vladisav Stefanovic
Journal:  Pathol Oncol Res       Date:  2010-12-02       Impact factor: 3.201

2.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

3.  Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.

Authors:  Ling Cao; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Yun Zheng; Jane R Dunlevy; Donald A Sens; Seema Somji
Journal:  J Appl Toxicol       Date:  2010-07       Impact factor: 3.446

4.  The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.

Authors:  Andrea Slusser-Nore; Scott H Garrett; Xu Dong Zhou; Donald A Sens; Mary Ann Sens; Seema Somji
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-10       Impact factor: 4.219

5.  The immunocytochemical demonstration of basement membrane deposition in transitional cell carcinoma of bladder.

Authors:  R J Zuk; S I Baithun; J E Martin; E L Cox; P A Revell
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.

Authors:  Antonio Lopez-Beltran; Maria J Requena; Jose Alvarez-Kindelan; Ana Quintero; Ana Blanca; Rodolfo Montironi
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

7.  Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.

Authors:  Ruowen Zhang; Liping Wang; Scott H Garrett; Donald A Sens; Jane R Dunlevy; Xu Dong Zhou; Seema Somji
Journal:  Exp Toxicol Pathol       Date:  2016-08-13

8.  Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.

Authors:  Behfar Ehdaie; Alexandra Maschino; Shahrokh F Shariat; Jorge Rioja; Robert J Hamilton; William T Lowrance; Stephen A Poon; Hikmat A Al-Ahmadie; Harry W Herr
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

9.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

10.  Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa).

Authors:  Seema Somji; Xu Dong Zhou; Aaron Mehus; Mary Ann Sens; Scott H Garrett; Krista L Lutz; Jane R Dunlevy; Yun Zheng; Donald A Sens
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.